Qingjiang Xiao

Title: Innovations by Qingjiang Xiao in Biomedicine

Introduction

Qingjiang Xiao is a notable inventor based in Xiamen, China. He has made significant contributions to the field of biomedicine, particularly in the development of modified interferons. With a total of 2 patents, his work focuses on enhancing the efficacy of treatments for viral infections.

Latest Patents

Qingjiang Xiao's latest patents include two innovative formulations of interferon modified by polyethylene glycol (PEG). The first patent, titled "Interferon alpha-2a modified by polyethylene glycol and methods of preparation thereof," describes a method for modifying interferon (IFN)-α2a at a specific Lys residue with a Y-shaped branched PEG derivative. This modification aims to improve the therapeutic use of IFN-α2a in medicines. The second patent, "Interferon alpha-2B modified by polyethylene glycol and methods of preparation thereof," details a similar modification for interferon-α2b, which can be utilized in creating a medicament for treating diseases such as Hepatitis C.

Career Highlights

Qingjiang Xiao is currently associated with Biosteed Gene Expression Tech. Co., Ltd. His work at this company emphasizes the importance of innovative approaches in the treatment of viral infections. His research has the potential to significantly impact the medical field by providing more effective therapeutic options.

Collaborations

Qingjiang Xiao collaborates with esteemed colleagues, including Weidong Zhou and Li Sun. Their combined expertise contributes to the advancement of biotechnological innovations.

Conclusion

Qingjiang Xiao's contributions to the field of biomedicine through his patented innovations highlight the importance of research in developing effective treatments for viral infections. His work continues to pave the way for advancements in medical therapies.